Notified Bodies, Authorized Reps And The CE Mark: Post-Brexit Uncertainty Clouds Future Regulations
This article was originally published in The Gray Sheet
Executive Summary
The soon-to-be-adopted Medical Device and In Vitro Diagnostic Regulations in the European Union are expected to take effect in the next three to five years, when the UK could be separate from the EU. What are the potential regulatory implications of the "Brexit" for device firms in the UK and throughout Europe?
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.